Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seres Therapeutics, Inc. (MCRB)  
$0.71 0.00 (-0.30%) as of 4:30 Fri 6/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 124,070,000
Market Cap: 87.88(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5599 - $5.72
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seres Therapeutics is a microbiome therapeutics platform company developing live biotherapeutic drugs. SER-109, Co.'s lead clinical candidate is an oral, purified bacterial spore-based microbiome therapeutic candidate consisting of a consortium of purified Firmicutes spores. Using Co.'s microbiome therapeutics platform, Co. is also developing SER-287 and SER-301 to treat ulcerative colitis. Co. evaluates microbiome pharmacokinetic and pharmacodynamic data from across its clinical and pre-clinical portfolios using its reverse translation microbiome therapeutics capabilities to conduct research on various indications, including inflammatory and immune diseases, cancer, and metabolic diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 8,738,243
Total Buy Value $0 $0 $0 $27,525,465
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 6,901 43,282 78,051 90,101
Total Sell Value $6,488 $45,780 $92,717 $168,989
Total People Sold 6 7 8 8
Total Sell Transactions 6 13 21 23
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 207
  Page 6 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Desrosier Thomas See Remarks   •       –      –    2018-01-26 4 S $11.02 $38,295 D/D (3,475) 6,525     -
   Desrosier Thomas See Remarks   •       –      –    2018-01-26 4 OE $0.00 $0 D/D 10,000 10,000     -
   Pomerantz Roger President and CEO   •       •      –    2018-01-24 4 OE $0.71 $28,571 D/D 40,241 324,537     -
   Aunins John G. See Remarks   •       –      –    2017-12-19 4/A S $10.14 $16,457 D/D (1,623) 195,502     -
   Aunins John G. See Remarks   •       –      –    2017-12-19 4/A OE $0.00 $0 D/D 5,000 197,125     -
   Aunins John G. Chief Technology Officer & EVP   •       –      –    2017-12-19 4 S $10.14 $16,457 D/D (1,623) 59,437     -
   Aunins John G. Chief Technology Officer & EVP   •       –      –    2017-12-19 4 OE $0.00 $0 D/D 5,000 61,060     -
   Pomerantz Roger President and CEO   •       •      –    2017-07-18 4 OE $0.71 $71,429 D/D 100,604 284,296     -
   Aunins John G. Chief Technology Officer & EVP   •       –      –    2016-08-29 4 AS $10.87 $102,069 D/D (9,390) 192,125     -
   Trucksis Michele Chief Medical Officer and EVP   •       –      –    2016-07-28 4 AS $35.18 $146,207 D/D (4,156) 0     -
   Trucksis Michele Chief Medical Officer and EVP   •       –      –    2016-07-28 4 OE $15.77 $65,540 D/D 4,156 4,156     -
   Aunins John G. Chief Technology Officer & EVP   •       –      –    2016-07-27 4 AS $35.00 $323,750 D/D (9,250) 201,515     -
   Trucksis Michele Chief Medical Officer and EVP   •       –      –    2016-07-27 4 AS $35.14 $1,337,512 D/D (38,064) 0     -
   Trucksis Michele Chief Medical Officer and EVP   •       –      –    2016-07-27 4 OE $15.77 $600,269 D/D 38,064 38,064     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-27 4 AS $35.00 $700,000 D/D (20,000) 183,692     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-27 4 OE $0.71 $14,200 D/D 20,000 203,692     -
   Aunins John G. Chief Technology Officer & EVP   •       –      –    2016-07-25 4 AS $34.18 $320,950 D/D (9,390) 210,765     -
   Aunins John G. Chief Technology Officer & EVP   •       –      –    2016-07-22 4 OE $0.48 $90,000 D/D 187,500 220,155     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-06 4 AS $29.27 $1,050,716 D/D (35,435) 183,692     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-06 4 OE $0.71 $25,159 D/D 35,435 219,127     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-05 4 AS $29.27 $1,546,758 D/D (52,776) 183,692     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-05 4 OE $0.71 $37,471 D/D 52,776 236,468     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-01 4 AS $29.12 $1,692,705 D/D (56,789) 183,692     -
   Pomerantz Roger President and CEO   •       •      –    2016-07-01 4 OE $0.71 $40,320 D/D 56,789 240,481     -
   Shaff Eric D. CFO and EVP   •       –      –    2016-06-30 4 AS $29.54 $133,905 D/D (4,533) 0     -
  207 Records found
  1  2  3  4  5  6  7  8  9   
  Page 6 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us